This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, which is ...

New treatments for dry macular degeneration are helping slow vision loss, and researchers are testing therapies that may restore sight. Here’s what to know. Dry age-related macular degeneration is the ...

A new study in mice hints at the promise of an eventual alternative treatment option for the 'wet' version of age-related macular degeneration (AMD). Researchers determined in mice that an enzyme ...

DAVENPORT, Iowa (KWQC) - February is Age-related Macular Degeneration (AMD) Awareness month. AMD is very common and is a leading cause of vision loss in people 50 years or older. With AMD you lose ...

Quitting smoking and getting regular eye exams may lower your risk of macular degeneration. Eating a Mediterranean diet can reduce your risk of advanced AMD by 41%. You can wear sunglasses that block ...

Share on Pinterest The FDA has approved biosimilars for macular degeneration treatment. recep-bg/Getty Images The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related ...

brolucizumab Beovu 6mg/0.05mL soln for intravitreal inj 6mg (0.05mL) once monthly (approx. 25–31 days) for the 1st 3 doses, followed by 6mg (0.05mL) once every 8–12wks ranibizumab Lucentis 6mg/mL ...